Pharmaceuticals

Kineret Market 2026–2035 expanding with anti-inflammatory treatments

March 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Kineret Market From 2026 To 2030?

The historical growth can be attributed to various factors, beginning with the unmet requirements in managing inflammatory disorders. This was further propelled by the clinical achievements of IL-1 blockade and enhanced diagnostic methods for rare syndromes. Additionally, the increasing integration of biologics within hospitals and the emergence of comprehensive long-term safety data have all contributed to this expansion.

The projected growth during the forecast period is primarily attributed to a heightened recognition of autoinflammatory diseases, the extension into new therapeutic areas, an increase in the use of biologics in pediatric populations, improved accessibility to specialized medical attention, and sustained innovation in biologic treatments. Throughout the same forecast period, significant trends are expected to include the broader application of IL-1 inhibitors, an escalation in the treatment of autoinflammatory diseases, expansion within pediatric inflammatory care, a growing preference for targeted cytokine therapies, and a rise in their use for rare inflammatory syndromes.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20129&type=smp

What Key Drivers Are Influencing The Growth Of The Kineret Market?

The rising incidence of autoimmune conditions is anticipated to fuel the expansion of the kineret market in the coming years. These conditions involve the body’s own immune system erroneously targeting its healthy cells, tissues, and organs, perceiving them as harmful foreign bodies. This growing occurrence of autoimmune disorders stems from a blend of genetic predispositions, environmental influences, and lifestyle choices. Kineret serves as a beneficial treatment option for autoimmune diseases, particularly effective in managing states of severe inflammation resulting from the immune system’s assault on the body’s own tissues. For example, a study encompassing 22 million individuals, reported in May 2023 by the National Institute for Health and Care Research (NIHR), a UK-based health and care research organization, indicates that autoimmune disorders currently affect roughly one in ten individuals. This study found 19 autoimmune diseases impacting approximately 10% of the population, specifically 13% of women and 7% of men. Consequently, the expanding prevalence of autoimmune diseases is stimulating the development of the kineret market.

Which Segments Are Included In The Analysis Of The Kineret Market?

The kineret market covered in this report is segmented –

1) By Indication: Treatment Of Rheumatoid Arthritis, Treatment Of Still’s Disease, Treatment Of Cryopyrin-Associated Periodic Syndromes, Treatment Of Neonatal-Onset Multisystem Inflammatory Disease (NOMIDN)

2) By Formulation: Injectable formulation, Pre-filled Syringes Or Auto-injectors

3) By Patient Demographics: Pediatric Patients, Adult Patients, Geriatric Patients

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Wholesalers And Distributors

5) By End-User: Hospitals, Specialty Clinics, Outpatient Treatment Centers, Home Healthcare Providers

Which Trends Are Impacting The Growth Of The Kineret Market?

A primary trend emerging in the Kineret market is the embrace of strategic alliances aimed at innovating Kineret-derived products and securing a competitive position. These collaborations empower businesses within the Kineret market to consolidate resources and specialized knowledge, enhance their research and development activities, expand their market footprint, and hasten the commercialization of products, thus cultivating innovation and advancement across the industry. For example, in May 2024, Swedish Orphan Biovitrum AB, a Sweden-based biopharmaceutical company, joined forces with Handok Inc., a South Korea-based pharmaceutical company, to release Kineret (anakinra) in South Korea. This partnership unites Handok’s local expertise with Sobi’s global biopharmaceutical capabilities, particularly within the field of rare diseases.

Which Key Industry Participants Are Active In The Kineret Market?

Major companies operating in the kineret market are Sobi (Swedish Orphan Biovitrum AB)

Read the full kineret market report here:

https://www.thebusinessresearchcompany.com/report/kineret-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Kineret Market?

North America was the largest region in the kineret market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kineret market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Kineret Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20129&type=smp

Browse Through More Reports Similar to the Global Kineret Market 2026, By The Business Research Company

Derivatives And Commodities Brokerage Market Report 2026

https://www.thebusinessresearchcompany.com/report/derivatives-and-commodities-brokerage-global-market-report

Derivatives And Commodities Brokerage Market Report 2026

https://www.thebusinessresearchcompany.com/report/derivatives-and-commodities-brokerage-global-market-report

Market Research Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/market-research-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795